Related Experiment Videos
[Fosfomycin-cefotaxime combination in severe staphylococcal infections in newborn infants]
Abstract:
Clinical and bacteriological effectiveness of the fosfomycin-cefotaxime combination is reported in four cases of serious staphylococcal infections in neonates (1 meningitis, 2 osteomyelitis, 1 superinfection of congenital varicella). Owing to the strong synergistic effect of this combination on methicillin-resistant staphylococcal strains, the authors suggest that the fosfomycin-cefotaxime combination should be considered for anti-staphylococcal therapy in neonates with deep tissue and/or methicillin-resistant infections.
Insights
The fosfomycin-cefotaxime combination shows promise for treating serious staphylococcal infections in newborns. This antibiotic pairing is particularly effective against methicillin-resistant strains, suggesting its use in deep-tissue neonatal infections.
Area of Science:
- Neonatal infectious diseases
- Pharmacology and therapeutics
- Bacteriology
Context:
- Serious staphylococcal infections pose significant risks to neonates.
- Limited treatment options exist for methicillin-resistant Staphylococcus strains in newborns.
- Neonatal intensive care units (NICUs) frequently encounter challenging bacterial infections.
Purpose:
- To evaluate the clinical and bacteriological effectiveness of a fosfomycin-cefotaxime combination in neonates with serious staphylococcal infections.
- To assess the synergistic activity of fosfomycin and cefotaxime against methicillin-resistant staphylococcal strains.
- To determine the potential utility of this combination in neonatal anti-staphylococcal therapy.
Summary:
- The study reports on four neonates with severe staphylococcal infections (meningitis, osteomyelitis, and varicella superinfection) treated with fosfomycin and cefotaxime.
- A strong synergistic effect was observed between fosfomycin and cefotaxime against methicillin-resistant staphylococcal strains.
- The combination demonstrated clinical and bacteriological effectiveness in these challenging cases.
Impact:
- The fosfomycin-cefotaxime combination is a potential therapeutic option for neonatal staphylococcal infections, especially those caused by methicillin-resistant strains.
- This combination may be particularly valuable for treating deep-tissue and resistant infections in neonates.
- Further investigation into this synergistic antibiotic combination could lead to improved treatment protocols for neonatal sepsis and other severe staphylococcal conditions.